Biochemical characterization of the core structure of α-synuclein filaments

被引:218
作者
Miake, H
Mizusawa, H
Iwatsubo, T
Hasegawa, M
机构
[1] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan
关键词
D O I
10.1074/jbc.M110551200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intracellular filamentous aggregates comprised of alpha-synuclein such as Lewy bodies and glial cytoplasmic inclusions are the defining hallmarks of a subset of neurodegenerative diseases including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. We have analyzed biochemical and structural properties of alpha-synuclein filaments assembled in vitro or extracted from brains of patients with multiple system atrophy and found that both types of filaments are insoluble to detergents and partially resistant to proteinase K digestion. Immunoelectron microscopy and immunoblot analysis showed that both amino and carboxyl termini of alpha-synuclein in in vitro assembled filaments were degraded by proteinase K treatment, whereas the central portion of alpha-synuclein is resistant to proteinase K and retains filamentous structures. Protein sequencing and mass spectrometric analyses of the proteinase K-resistant, minimal fragment of 7 kDa revealed that amino acid residues 31-109 of alpha-synuclein constitute the core unit of the filaments. These observations suggest that the central half of the alpha-synuclein polypeptide, containing five tandem repeats as well as a part of the carboxyl-terminal acidic region, forms the core structure of alpha-synuclein filaments, which is coated by the amino- and carboxyl-terminaI portions at the periphery.
引用
收藏
页码:19213 / 19219
页数:7
相关论文
共 35 条
[1]  
Baba M, 1998, AM J PATHOL, V152, P879
[2]   Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs [J].
Biere, AL ;
Wood, SJ ;
Wypych, J ;
Steavenson, S ;
Jiang, YJ ;
Anafi, D ;
Jacobsen, FW ;
Jarosinski, MA ;
Wu, GM ;
Louis, JC ;
Martin, F ;
Narhi, LO ;
Citron, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34574-34579
[3]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[4]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[5]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[6]   THE MICROTUBULE BINDING REPEATS OF TAU PROTEIN ASSEMBLE INTO FILAMENTS LIKE THOSE FOUND IN ALZHEIMERS-DISEASE [J].
CROWTHER, RA ;
OLESEN, OF ;
JAKES, R ;
GOEDERT, M .
FEBS LETTERS, 1992, 309 (02) :199-202
[7]   Synthetic filaments assembled from C-terminally truncated α-synuclein [J].
Crowther, RA ;
Jakes, R ;
Spillantini, MG ;
Goedert, M .
FEBS LETTERS, 1998, 436 (03) :309-312
[8]   Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain [J].
Crowther, RA ;
Daniel, SE ;
Goedert, M .
NEUROSCIENCE LETTERS, 2000, 292 (02) :128-130
[9]   Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited -: NAC and α-synuclein are not associated with Aβ amyloid [J].
Culvenor, JG ;
McLean, CA ;
Cutt, S ;
Campbell, BCV ;
Maher, F ;
Jäkälä, P ;
Hartmann, T ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1173-1181
[10]   Widespread alterations of α-synuclein in multiple system atrophy [J].
Dickson, DW ;
Liu, WK ;
Hardy, J ;
Farrer, M ;
Mehta, N ;
Uitti, R ;
Mark, M ;
Zimmerman, T ;
Golbe, L ;
Sage, J ;
Sima, A ;
D'Amato, C ;
Albin, R ;
Gilman, S ;
Yen, SH .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1241-1251